Literature DB >> 21813106

Relation of visceral adiposity to circulating natriuretic peptides in ambulatory individuals.

Susan Cheng1, Caroline S Fox, Martin G Larson, Joseph M Massaro, Elizabeth L McCabe, Abigail May Khan, Daniel Levy, Udo Hoffmann, Christopher J O'Donnell, Karen K Miller, Christopher Newton-Cheh, Andrea D Coviello, Shalender Bhasin, Ramachandran S Vasan, Thomas J Wang.   

Abstract

Natriuretic peptides have important roles in the regulation of vasomotor tone, salt homeostasis, and ventricular remodeling. Lower natriuretic peptide levels observed in obese individuals may underlie the greater cardiovascular risk associated with obesity. Thus the aim of this study was to determine whether lower natriuretic peptide levels in obesity are attributable to differences in regional fat distribution. We investigated the relation of plasma N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) to regional adiposity in 1,873 community-based individuals (46% women, mean age 45 years). Subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) volumes were measured by multidetector computed tomography. In gender-specific multivariable analyses adjusting for age and blood pressure, log NT-pro-BNP was inversely associated with VAT in men (beta -0.11 per standard deviation increment, p <0.001) and women (beta -0.19, p <0.001). Log NT-pro-BNP was inversely associated with SAT in women only (beta -0.14, p <0.001). In models containing VAT and SAT, only VAT was significantly associated with log NT-pro-BNP (men, beta -0.137, p <0.001; women, beta -0.184, p <0.001). VAT remained associated with log NT-pro-BNP even after adjustment for body mass index and waist circumference (beta -0.119, p <0.001) and in analyses restricted to nonobese patients (beta -0.165, p <0.001). Adjustment for insulin resistance attenuated the associations of NT-pro-BNP with VAT and SAT. In conclusion, this study demonstrates that circulating NT-pro-BNP is related to variations in regional and particularly visceral adiposity. These findings suggest that excess visceral adiposity and concomitant hyperinsulinemia may contribute to the natriuretic peptide "deficiency" observed in obesity.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21813106      PMCID: PMC3175269          DOI: 10.1016/j.amjcard.2011.05.033

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  29 in total

1.  Impact of age and sex on plasma natriuretic peptide levels in healthy adults.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Eric P Leip; Emelia J Benjamin; Peter W F Wilson; Patrice Sutherland; Torbjorn Omland; Ramachandran S Vasan
Journal:  Am J Cardiol       Date:  2002-08-01       Impact factor: 2.778

2.  Visceral fat is negatively associated with B-type natriuretic peptide levels in patients with advanced type 2 diabetes.

Authors:  Takako Sugisawa; Ichiro Kishimoto; Yoshihiro Kokubo; Ayako Nagumo; Hisashi Makino; Yoshihiro Miyamoto; Yasunao Yoshimasa
Journal:  Diabetes Res Clin Pract       Date:  2010-04-03       Impact factor: 5.602

3.  Role of insulin and atrial natriuretic peptide in sodium retention in insulin-treated IDDM patients during isotonic volume expansion.

Authors:  R Trevisan; P Fioretto; A Semplicini; G Opocher; F Mantero; S Rocco; G Remuzzi; A Morocutti; G Zanette; V Donadon
Journal:  Diabetes       Date:  1990-03       Impact factor: 9.461

4.  N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome.

Authors:  Michael H Olsen; Tine W Hansen; Marina K Christensen; Finn Gustafsson; Susanne Rasmussen; Kristian Wachtell; Knut Borch-Johnsen; Hans Ibsen; Torben Jørgensen; Per Hildebrandt
Journal:  Hypertension       Date:  2005-08-29       Impact factor: 10.190

5.  Moderate alcohol consumption, estrogen replacement therapy, and physical activity are associated with increased insulin sensitivity: is abdominal adiposity the mediator?

Authors:  Jerry R Greenfield; Katherine Samaras; Arthur B Jenkins; Paul J Kelly; Tim D Spector; Lesley V Campbell
Journal:  Diabetes Care       Date:  2003-10       Impact factor: 19.112

6.  Insulin blunts the natriuretic action of atrial natriuretic peptide in hypertension.

Authors:  S Abouchacra; A D Baines; B Zinman; K L Skorecki; A G Logan
Journal:  Hypertension       Date:  1994-06       Impact factor: 10.190

7.  Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis.

Authors:  Muredach P Reilly; Megan L Wolfe; Thomas Rhodes; Cynthia Girman; Nehal Mehta; Daniel J Rader
Journal:  Circulation       Date:  2004-08-02       Impact factor: 29.690

8.  Effects of acute hyperinsulinemia on plasma atrial and brain natriuretic peptide concentrations.

Authors:  A Tanabe; M Naruse; T Wasada; K Naruse; T Yoshimoto; Y Omori; H Demura
Journal:  Eur J Endocrinol       Date:  1995-06       Impact factor: 6.664

9.  Natriuretic peptide-dependent lipolysis in fat cells is a primate specificity.

Authors:  Coralie Sengenès; Alexia Zakaroff-Girard; Agnès Moulin; Michel Berlan; Anne Bouloumié; Max Lafontan; Jean Galitzky
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-07       Impact factor: 3.619

10.  Direct effects of high glucose and insulin on protein synthesis in cultured cardiac myocytes and DNA and collagen synthesis in cardiac fibroblasts.

Authors:  Takeshi Tokudome; Takeshi Horio; Fumiki Yoshihara; Shin-Ichi Suga; Yuhei Kawano; Masakazu Kohno; Kenji Kangawa
Journal:  Metabolism       Date:  2004-06       Impact factor: 8.694

View more
  22 in total

Review 1.  Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure.

Authors:  Chaitanya Madamanchi; Hassan Alhosaini; Arihiro Sumida; Marschall S Runge
Journal:  Int J Cardiol       Date:  2014-08-09       Impact factor: 4.164

2.  Changes in N-terminal pro-B-type natriuretic peptide and incidence of diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  O A Sanchez; D A Duprez; H Bahrami; C A Peralta; L B Daniels; J A Lima; A Maisel; A R Folsom; D R Jacobs
Journal:  Diabetes Metab       Date:  2015-06-03       Impact factor: 6.041

3.  Insulin resistance is associated with increased concentrations of NT-proBNP in rheumatoid arthritis: IL-6 as a potential mediator.

Authors:  William S Bradham; Michelle J Ormseth; Annette Oeser; Joseph F Solus; Tebeb Gebretsadik; Ayumi Shintani; C Michael Stein
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

4.  Racial Differences in Natriuretic Peptide Levels: The Dallas Heart Study.

Authors:  Deepak K Gupta; James A de Lemos; Colby R Ayers; Jarett D Berry; Thomas J Wang
Journal:  JACC Heart Fail       Date:  2015-06-10       Impact factor: 12.035

Review 5.  Precision Medicine for Heart Failure with Preserved Ejection Fraction: An Overview.

Authors:  Sanjiv J Shah
Journal:  J Cardiovasc Transl Res       Date:  2017-06-05       Impact factor: 4.132

6.  Adiposity and Incident Heart Failure and its Subtypes: MESA (Multi-Ethnic Study of Atherosclerosis).

Authors:  Vishal N Rao; Di Zhao; Matthew A Allison; Eliseo Guallar; Kavita Sharma; Michael H Criqui; Mary Cushman; Roger S Blumenthal; Erin D Michos
Journal:  JACC Heart Fail       Date:  2018-10-10       Impact factor: 12.035

Review 7.  Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers.

Authors:  Ravi Dhingra; Ramachandran S Vasan
Journal:  Trends Cardiovasc Med       Date:  2016-07-28       Impact factor: 6.677

8.  Higher natriuretic peptide levels associate with a favorable adipose tissue distribution profile.

Authors:  Ian J Neeland; Benjamin R Winders; Colby R Ayers; Sandeep R Das; Alice Y Chang; Jarett D Berry; Amit Khera; Darren K McGuire; Gloria L Vega; James A de Lemos; Aslan T Turer
Journal:  J Am Coll Cardiol       Date:  2013-04-16       Impact factor: 24.094

9.  Treatment with brain natriuretic peptide prevents the development of cardiac dysfunction in obese diabetic db/db mice.

Authors:  Eric Plante; Ahmed Menaouar; Bogdan A Danalache; Tom L Broderick; Marek Jankowski; Jolanta Gutkowska
Journal:  Diabetologia       Date:  2014-03-05       Impact factor: 10.122

Review 10.  B-type natriuretic peptide levels and benign adiposity in obese heart failure patients.

Authors:  Vasiliki Katsi; Maria Marketou; Alexios S Antonopoulos; Dimitrios Vrachatis; Fragkiskos Parthenakis; Dimitris Tousoulis
Journal:  Heart Fail Rev       Date:  2019-03       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.